Journal profile · UROLOGY & NEPHROLOGY
UROLOGE
ISSN 0340-2592 · eISSN 1433-0563 · Springer Medizin · GERMANY · 12 issues per year · Founded 1996
UROLOGE: impact factor 0.4; hybrid open access; APC about USD 3,090; review 3–8 weeks (community reports); community-reported acceptance: easy; 131 articles a year; indexed in Scopus.
Scope
Aims, scope and focus
UROLOGE is published by Springer Medizin. By OpenAlex counts of its recent articles, its largest topics are Medical and Health Sciences Research, Bladder and Urothelial Cancer Treatments and Prostate Cancer Diagnosis and Treatment, together about 24.5% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Zielsetzung der Zeitschrift Die Urologie ist ein international angesehenes Publikationsorgan. Die Zeitschrift widmet sich allen Aspekten der Urologie und dient der Fortbildung von niedergelassenen und in der Klinik tätigen Urolog*innen. Im Vordergrund stehen Prävention, diagnostische Vorgehensweisen und Komplikationsmanagement sowie moderne Therapiestrategien. Umfassende Übersichtsarbeiten zu einem aktuellen Schwerpunktthema sind das Kernstück jeder Ausgabe. Im Mittelpunkt steht dabei gesichertes Wissen zu Diagnostik und Therapie mit hoher Relevanz für die tägliche Arbeit einschließlich konkreter Handlungsempfehlungen. Frei eingereichte Originalien ermöglichen die Präsentation wichtiger klinischer Studien und dienen dem wissenschaftlichen Austausch. Kasuistiken zeigen interessante Fallbeispiele und ungewöhnliche Krankheits- bzw. Behandlungsverläufe. Beiträge der Rubrik 'CME Zertifizierte Fortbildung' bieten gesicherte Ergebnisse wissenschaftlicher Forschung und machen ärztliche Erfahrung für die tägliche Praxis nutzbar. Zertifizierte Fragebögen ermöglichen die Überprüfung des gewonnenen Wissens und das Erwerben von CME-Punkten online. Die Rubrik orientiert sich an der Weiterbildungsordnung des Fachgebiets. Aims & Scope Die Urologie is an internationally respected journal covering all areas of urology. The focus is on prevention, diagnostic approaches, management of complications, and current therapy strategies. The journal provides information for all urologists working in practical and clinical environments and scientists who are particularly interested in issues of urology. Comprehensive reviews on a specific topical issue focus on providing evidenced based information on diagnostics and therapy. Freely submitted original papers allow the presentation of important clinical studies and serve scientific exchange. Case reports feature interesting cases and aim at optimizing diagnostic and therapeutic strategies. Review articles under the rubric 'Continuing Medical Education' present verified results of scientific research and their integration into daily practice. Review All articles of Die Urologie are reviewed. Original papers and case reports undergo a peer review process. Declaration of Helsinki All manuscripts submitted for publication presenting results from studies on probands or patients must comply with the Declaration of Helsinki. Indexed in Science Citation Index Expanded, Medline, EMBASE and Scopus.
From the journal's Aims & Scope
Research area (LetPub): UROLOGY & NEPHROLOGY
Editor-in-chief Axel HeidenreichPublisher website
Editorial board by country: none in mainland China; most named Germany 110, Switzerland 4, Austria 3 (117 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical and Health Sciences ResearchMedicine8.7%
- Bladder and Urothelial Cancer TreatmentsMedicine8%
- Prostate Cancer Diagnosis and TreatmentMedicine7.7%
- Urinary Bladder and Prostate ResearchMedicine7.4%
- Prostate Cancer Treatment and ResearchMedicine6.8%
- Urological Disorders and TreatmentsMedicine6.1%
- Medical Practices and RehabilitationHealth Professions5.1%
- Health and Medical StudiesHealth Professions5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEMEDLINEEmbaseCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.4LetPub ·
- Impact factor (publisher) 2025
- 0.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.8Publisher website ·
- CiteScore 2026-06
- 0.9LetPub ·
- SJR 2026-06
- 0.17LetPub ·
- SNIP 2026-06
- 0.3LetPub ·
- h-index
- 24LetPub ·
- h-index
- 36OpenAlex ·
- i10-index
- 601OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 11.58%LetPub ·
Volume
- Articles per year
- 131LetPub ·
- Downloads per year (publisher) 2025
- 423,000Publisher website ·
Articles by year OpenAlex count · 5,726 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2022 | 83 | 26 | 71 |
| 2021 | 301 | 106 | 514 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,090 / EUR 2,590 / GBP 2,190 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteData availability, Open access
- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Die Urologie, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Medizin
- Country or region
- GERMANY
- Language
- German
- Frequency
- 12 issues per year
- Founded
- 1996
- ISSN
- 0340-2592
- Electronic ISSN
- 1433-0563
- Latest issue on the website
- Volume 65, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about UROLOGE
What is the impact factor of UROLOGE?
The latest impact factor listed by LetPub is 0.4; CiteScore 0.9, h-index 36.
How long does peer review take at UROLOGE?
Authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of UROLOGE based?
Of the 117 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Germany (110), Switzerland (4) and Austria (3). Counted from the institutions listed on the board page; for reference only.
Which databases index UROLOGE?
According to LetPub and DOAJ records, UROLOGE is indexed in Scopus. The journal's website also lists SCIE, MEDLINE, Embase and Current Contents; that list has not been checked against each database.
Is UROLOGE open access, and what is the APC?
UROLOGE is a hybrid journal. For open-access publication: APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .